These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9546687)

  • 1. Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome: a possible pathogenic role.
    Ardiles LG; Olavarría F; Elgueta M; Moya P; Mezzano S
    Nephron; 1998; 78(3):278-83. PubMed ID: 9546687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies in D+ hemolytic uremic syndrome.
    te Loo M; van der Velden T; Onland W; van den Heuvel L; Monnens L
    Pediatr Nephrol; 2002 Dec; 17(12):1042-6. PubMed ID: 12478355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome.
    Guglielmone HA; Fernandez EJ
    J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in acute poststreptococcal glomerulonephritis and streptococcal impetigo.
    Ardiles L; Ramirez P; Moya P; Caorsi I; Mezzano S
    Nephron; 1999 Sep; 83(1):47-52. PubMed ID: 10461035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M; Davies KA; Gordon C; Loizou S
    Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
    Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.
    Cucurull E; Espinoza LR; Mendez E; Molina JF; Molina J; Ordi-Ros J; Gharavi AE
    Lupus; 1999; 8(2):134-41. PubMed ID: 10192508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibodies in childhood rheumatic disorders.
    Gedalia A; Molina JF; García CO; Doggett S; Espinoza LR; Gharavi AE
    Lupus; 1998; 7(8):551-3. PubMed ID: 9863898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. A case report and review of the literature.
    Kniaz D; Eisenberg GM; Elrad H; Johnson CA; Valaitis J; Bregman H
    Am J Nephrol; 1992; 12(1-2):126-33. PubMed ID: 1492877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
    Sebastiani GD; Galeazzi M; Tincani A; Piette JC; Font J; Allegri F; Mathieu A; Smolen J; de Ramon Garrido E; Fernandez-Nebro A; Jedryka-Goral A; Papasteriades C; Morozzi G; Bellisai F; De Pitá O; Marcolongo R
    Scand J Rheumatol; 1999; 28(6):344-51. PubMed ID: 10665739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis.
    Serra CR; Rodrigues SH; Silva NP; Sztajnbok FR; Andrade LE
    Clin Exp Rheumatol; 1999; 17(3):375-80. PubMed ID: 10410276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease.
    Gupta M; Johann-Liang R; Bussel JB; Gersony WM; Lehman TJ
    Cardiology; 2002; 97(4):180-2. PubMed ID: 12145471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients.
    Liou HH; Wang CR; Chen CJ; Chen RC; Chuang CY; Chiang IP; Tsai MC
    Lupus; 1996 Aug; 5(4):307-12. PubMed ID: 8869904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.